Proteinuria reduction with SGLT2 inhibitors in a patient treated with tyrosine kinase inhibitor lenvatinib
Article in Journal of Nephrology (July 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma
Article in Oncology (June 2023)
Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
Article in Frontiers in Oncology (March 2023)